Informa plc (LON:INF) Given Consensus Recommendation of “Buy” by Brokerages

Shares of Informa plc (LON:INF) have been given a consensus recommendation of “Buy” by the six analysts that are covering the company, Marketbeat reports. Six analysts have rated the stock with a buy rating. The average 1-year target price among analysts that have issued a report on the stock in the last year is GBX 1,135.

Several equities research analysts have weighed in on the stock. Deutsche Bank Aktiengesellschaft restated a “buy” rating and issued a GBX 1,140 target price on shares of Informa in a research note on Friday, July 31st. Citigroup increased their price objective on Informa from GBX 990 to GBX 1,090 and gave the company a “buy” rating in a report on Wednesday, August 12th. Berenberg Bank raised their price objective on Informa from GBX 965 to GBX 1,040 and gave the stock a “buy” rating in a research report on Friday, July 31st. Finally, JPMorgan Chase & Co. dropped their target price on Informa from GBX 1,300 to GBX 1,285 and set an “overweight” rating on the stock in a research note on Thursday, July 2nd.

Informa Price Performance

INF opened at GBX 897.60 on Tuesday. The business’s 50-day moving average is GBX 894.05 and its two-hundred day moving average is GBX 833.65. Informa has a 1 year low of GBX 719 and a 1 year high of GBX 1,000. The company has a debt-to-equity ratio of 64.99, a current ratio of 0.55 and a quick ratio of 1.70. The firm has a market capitalization of £11.22 billion, a PE ratio of 52.49, a price-to-earnings-growth ratio of 0.75 and a beta of 0.68.

Informa (LON:INF) last released its quarterly earnings results on Thursday, July 30th. The company reported GBX 26.70 EPS for the quarter. Informa had a net margin of 5.43% and a return on equity of 3.90%. Research analysts anticipate that Informa will post 59.3240265 earnings per share for the current fiscal year.

About Informa

Our events, digital products and academic research services connect specialists with knowledge, helping them learn more, know more and do more.

We do this in dozens of specialist markets and subject matter categories, including in Healthcare & Pharma, Technology, Finance, Education, Marketing, Health & Nutrition, Foodservice, and many more.

And we do this through a range of products and services, including major live events, specialist media and content, expert research articles, books and open research platforms, accredited training, buyer discovery services, and digital demand and lead-generation services.